Tuesday, December 3, 2024
9:55 AM EST – Satellos Bioscience Inc. : Announced today that Frank Gleeson, Co-founder and CEO will participate in Oppenheimer’s Movers in Rare Disease Summit taking place in New York City on December 12. Satellos Bioscience Inc. (T.MSCL) shares were unchanged at 0.71.
Stocks in Play: Satellos Bioscience Inc., Tue, 03 Dec 2024 09:57:06 EST